|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0013216,
umls-concept:C0030705,
umls-concept:C0033684,
umls-concept:C0205216,
umls-concept:C0242957,
umls-concept:C0449438,
umls-concept:C0597879,
umls-concept:C0598086,
umls-concept:C0598388,
umls-concept:C0678034,
umls-concept:C0678222,
umls-concept:C0750729,
umls-concept:C0814225,
umls-concept:C1274040,
umls-concept:C1415887,
umls-concept:C1419040,
umls-concept:C1420433,
umls-concept:C1424666,
umls-concept:C1512890,
umls-concept:C1514559,
umls-concept:C1518988,
umls-concept:C1707520
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2003-3-25
|
|
pubmed:abstractText |
The objective of this study was to clarify the prognostic and predictive value of immunoreactivity for the cyclin-dependent kinase inhibitor p27(Kip1) in patients with early-stage breast carcinoma and to investigate its relation with clinicopathologic features and other markers.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
pubmed-author:ByrneMichael JMJ,
pubmed-author:Castiglione-GertschMonicaM,
pubmed-author:CoatesAlan SAS,
pubmed-author:CollinsJohnJ,
pubmed-author:Cortés-FunesHernanH,
pubmed-author:GelberRichard DRD,
pubmed-author:GoldhirschAronA,
pubmed-author:GolouhRastkoR,
pubmed-author:GrigolatoPiergioranniP,
pubmed-author:GustersonBarry ABA,
pubmed-author:International Breast Cancer Study Group,
pubmed-author:LindtnerJuriiJ,
pubmed-author:LitmanHeatherH,
pubmed-author:MaffiniFaustoF,
pubmed-author:Martinez-TelloFrancisco JFJ,
pubmed-author:MasulloMicheleM,
pubmed-author:PriceKarenK,
pubmed-author:ShilkinKeith BKB,
pubmed-author:SimonciniEddaE,
pubmed-author:SpataroVito JVJ,
pubmed-author:VialeGiuseppeG
|
|
pubmed:copyrightInfo |
Copyright 2003 American Cancer Society.DOI 10.1002/cncr.11224
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
97
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1591-600
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:12655514-Adult,
pubmed-meshheading:12655514-Aged,
pubmed-meshheading:12655514-Breast Neoplasms,
pubmed-meshheading:12655514-Cell Cycle Proteins,
pubmed-meshheading:12655514-Chemotherapy, Adjuvant,
pubmed-meshheading:12655514-Cyclin-Dependent Kinase Inhibitor p27,
pubmed-meshheading:12655514-Cyclin-Dependent Kinases,
pubmed-meshheading:12655514-Disease-Free Survival,
pubmed-meshheading:12655514-Female,
pubmed-meshheading:12655514-Humans,
pubmed-meshheading:12655514-Immunohistochemistry,
pubmed-meshheading:12655514-Lymphatic Metastasis,
pubmed-meshheading:12655514-Middle Aged,
pubmed-meshheading:12655514-Predictive Value of Tests,
pubmed-meshheading:12655514-Prognosis,
pubmed-meshheading:12655514-Randomized Controlled Trials as Topic,
pubmed-meshheading:12655514-Receptor, erbB-2,
pubmed-meshheading:12655514-Tumor Markers, Biological,
pubmed-meshheading:12655514-Tumor Suppressor Proteins
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V.
|
|
pubmed:affiliation |
Department of Medical Oncology, Ospedale San Giovanni, Bellinzona, Switzerland. vito.spataro@blue.ch
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
